Predictors of Long-Term Survival Among High-Grade Serous Ovarian Cancer Patients
Overview
Oncology
Public Health
Authors
Affiliations
Background: Relatively little is known about factors associated with long-term survival (LTS) following a diagnosis of ovarian cancer.
Methods: We conducted a retrospective study of high-grade serous ovarian cancer (HGSOC) to explore predictors of LTS (defined as ≥7 years of survival) using electronic medical record data from a network of integrated health care systems. Multivariable logistic regression with forward selection was used to compare characteristics of women who survived ≥7 years after diagnosis ( = 148) to those who died within 7 years of diagnosis ( = 494).
Results: Our final model included study site, age, stage at diagnosis, CA-125, comorbidity score, receipt of chemotherapy, BMI, and four separate comorbid conditions: weight loss, depression, hypothyroidism, and liver disease. Of these, only younger age, lower stage, and depression were statistically significantly associated with LTS.
Conclusions: We did not identify any new characteristics associated with HGSOC survival.
Impact: Prognosis of ovarian cancer generally remains poor. Large, pooled studies of ovarian cancer are needed to identify characteristics that may improve survival.
Habteyes A, Deressa J, Kassa R BMC Womens Health. 2025; 25(1):36.
PMID: 39849505 PMC: 11756220. DOI: 10.1186/s12905-025-03566-w.
Neumann C, Kranenberg E, Schenk A, Kiefer N, Hilbert T, Klaschik S Healthcare (Basel). 2024; 12(12).
PMID: 38921332 PMC: 11203900. DOI: 10.3390/healthcare12121218.
Association of allostatic load with overall survival in epithelial ovarian cancer.
Borho L, Bao R, Elishaev E, Dinkins K, OBrien E, Berger J Gynecol Oncol. 2024; 186:204-210.
PMID: 38843663 PMC: 11216875. DOI: 10.1016/j.ygyno.2024.05.031.
Yang X, Zheng M, Ning Y, Sun J, Yu Y, Zhang S J Transl Med. 2023; 21(1):456.
PMID: 37434173 PMC: 10334653. DOI: 10.1186/s12967-023-04284-3.
Cuello M, Gomez F, Wichmann I, Suarez F, Kato S, Orlandini E Cancers (Basel). 2023; 15(4).
PMID: 36831500 PMC: 9953877. DOI: 10.3390/cancers15041156.